We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
263 hedge funds and large institutions have $1.31B invested in Amphastar Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 84 increasing their positions, 100 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
220% more call options, than puts
Call options by funds: $1.02M | Put options by funds: $318K
0.35% more ownership
Funds ownership: 72.79% → 73.14% (+0.35%)
6% less funds holding
Funds holding: 279 → 263 (-16)
16% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 100
24% less capital invested
Capital invested by funds: $1.72B → $1.31B (-$412M)
28% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 50
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
263
Holders Change
-16
Holders Change %
-5.73%
% of All Funds
3.46%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
36
Increased
84
Reduced
100
Closed
50
Calls
$1.02M
Puts
$318K
Net Calls
+$699K
Net Calls Change
-$2.09M
Top Buyers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$61.6M |
| 2 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$20.1M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
+$19.5M |
| 4 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$11.3M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.81M |
